IRIS
MACCARRONE, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.304
AS - Asia 3.522
EU - Europa 1.929
SA - Sud America 307
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 8
Totale 27.109
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.245
SG - Singapore 2.554
CN - Cina 422
DE - Germania 314
UA - Ucraina 278
BR - Brasile 269
IT - Italia 224
IE - Irlanda 213
HK - Hong Kong 200
RU - Federazione Russa 145
FR - Francia 144
SE - Svezia 143
GB - Regno Unito 119
PL - Polonia 119
KR - Corea 110
VN - Vietnam 93
NL - Olanda 81
FI - Finlandia 68
JP - Giappone 29
CZ - Repubblica Ceca 25
MX - Messico 25
CA - Canada 24
IN - India 22
ZA - Sudafrica 19
BD - Bangladesh 14
AR - Argentina 12
BE - Belgio 10
EU - Europa 10
KG - Kirghizistan 10
AT - Austria 8
IQ - Iraq 8
AU - Australia 7
IR - Iran 7
LT - Lituania 7
EC - Ecuador 6
ES - Italia 6
ID - Indonesia 6
IL - Israele 6
TR - Turchia 6
UZ - Uzbekistan 6
CL - Cile 5
DK - Danimarca 5
RS - Serbia 5
DM - Dominica 4
PY - Paraguay 4
CH - Svizzera 3
CO - Colombia 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
TW - Taiwan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BH - Bahrain 2
HU - Ungheria 2
JO - Giordania 2
NO - Norvegia 2
QA - Qatar 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MA - Marocco 1
MK - Macedonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 27.109
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.906
Wilmington 5.612
Houston 4.889
Fairfield 815
Ann Arbor 548
Singapore 493
Chandler 384
Ashburn 380
Seattle 300
Cambridge 254
Beijing 242
Jacksonville 242
Dublin 204
Hong Kong 196
Medford 159
Santa Clara 104
Kraków 101
New York 97
Los Angeles 79
Lawrence 75
Dearborn 64
The Dalles 61
Rome 58
Buffalo 44
Dallas 44
Mülheim 37
Ho Chi Minh City 35
San Diego 34
Council Bluffs 32
Menlo Park 31
Munich 30
São Paulo 30
Zhengzhou 29
Brno 24
Hanoi 24
Milan 21
Tokyo 21
London 19
Moscow 18
Redwood City 17
Chicago 16
Norwalk 16
Nuremberg 16
San Mateo 16
Saint Petersburg 15
University Park 15
Falls Church 14
Mountain View 14
Warsaw 14
Brooklyn 12
Denver 12
Redondo Beach 12
Kunming 11
Montreal 11
San Francisco 11
Stockholm 11
Brussels 10
Chennai 10
Columbus 10
Mexico City 10
Nanjing 10
Palo Alto 10
Phoenix 10
Verona 10
Bari 9
Guangzhou 9
Helsinki 9
Johannesburg 9
Boston 8
Nürnberg 8
Poplar 8
Seoul 8
Atlanta 7
Curitiba 7
Rio de Janeiro 7
Salt Lake City 7
Toronto 7
Boardman 6
Detroit 6
Hefei 6
Shanghai 6
Berlin 5
Jinan 5
Mcallen 5
Orem 5
Porto Alegre 5
Secaucus 5
Belo Horizonte 4
Biên Hòa 4
Brasília 4
Campinas 4
Cape Town 4
Da Nang 4
Frankfurt am Main 4
Hounslow 4
Lappeenranta 4
Milwaukee 4
Querétaro 4
Quito 4
Redmond 4
Totale 22.258
Salva come PNG Salva come JPEG
Nome #
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis 650
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 597
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 594
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 587
TRPV1 channels facilitate glutamate transmission in the striatum 585
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 578
Urinary N-acetyl-beta-D-glucosaminidase concentration in patients with spinal cord injury: relationship with urodynamic parameters 575
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 567
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? 553
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 552
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 534
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 486
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. 478
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 466
Downstream effects of endocannabinoid on blood cells: Implications for health and disease 466
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour 459
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 455
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 455
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 453
Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells 449
TRPV1 channels regulate cortical excitability in humans 448
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors 447
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 445
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 444
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 428
Trans-crocetin improves amyloid-β degradation in monocytes from Alzheimer's Disease patients 423
Structure-to-function relationship of mini-lipoxygenase, a 60-kDa fragment of soybean lipoxygenase-1 with lower stability but higher enzymatic activity 423
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission 419
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 419
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling 418
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 416
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System 414
The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases 413
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 407
Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons 403
The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases 401
HIV-1 coat glycoprotein gp120 induces apoptosis in rat brain neocortex by deranging the arachidonate cascade in favor of prostanoids 400
Type-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells . 399
Comment on "Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis" 393
null 393
The endocannabinoid system in targeting inflammatory neurodegenerative diseases 392
GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma 392
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis 391
Stimulation of autophagy by rapamycin protects neurons from remote degeneration after acute focal brain damage 386
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases 384
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis 383
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo 378
Altered anandamide degradation in attention-deficit/hyperactivity disorder 377
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor 375
In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system 371
Cannabinoid receptor signaling in neurodegenerative diseases: a potential role for membrane fluidity disturbance 359
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum 353
TRPV1 channels regulate cortical excitability in humans 290
Potential for diagnosis versus therapy monitoring of attention deficit hyperactivity disorder: a new epigenetic biomarker interacting with both genotype and auto-immunity 273
Early alteration of distribution and activity of hippocampal type-1 cannabinoid receptor in Alzheimer's disease-like mice overexpressing the human mutant amyloid precursor protein 247
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 220
From Traumatic Childhood to Cocaine Abuse: The Critical Function of the Immune System 207
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 191
Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases 179
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity 165
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? 165
Platelet activation: a new vascular activity of anandamide [2] 161
Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response 138
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 137
The endocannabinoid hydrolase FAAH is an allosteric enzyme 135
Assay of NAPE-PLD Activity 130
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity 116
Lipid Discovery by Combinatorial Screening and Untargeted LC-MS/MS 109
Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1 102
Plant-Derived and Endogenous Cannabinoids in Epilepsy 100
Biochimica del sangue 84
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients 69
Endomorphin-1 prevents lipid accumulation via CD36 down-regulation and modulates cytokines release from human lipid-laden macrophages 67
Conformational Dynamics of Lipoxygenases and Their Interaction with Biological Membranes 62
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1 58
Effects of Long-Term Oral Administration of N-Palmitoylethanolamine in Subjects with Mild Cognitive Impairment: Study Protocol 58
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 57
Radiometric Assay of NAPE-PLD Activity 52
Chemical proteomics reveals off-targets of the anandamide reuptake inhibitor WOBE437 48
Endocannabinoids and platelets - Signalling pathways 40
In silico and in vitro analysis of major cannabis-derived compounds as fatty acid amide hydrolase inhibitors 39
Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential 38
DNA-Protein-Interaction (DPI)-ELISA Assay for PPAR-γ Receptor Binding 38
Fatty acid amide hydrolase, anandamide, and neurological diseases 35
FAAH Modulators from Natural Sources: A Collection of New Potential Drugs 34
Endocannabinoids and platelets - Differentiation 34
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models 20
Totale 27.331
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.182
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.539 0 0 0 0 0 355 443 367 81 91 145 57
2021/2022816 19 91 38 43 19 71 37 33 54 105 82 224
2022/2023955 108 83 20 126 69 234 74 60 90 5 64 22
2023/2024301 29 11 14 15 27 87 8 23 2 3 24 58
2024/20253.259 87 398 176 102 38 140 152 80 164 123 1.053 746
2025/20261.529 248 186 369 319 383 24 0 0 0 0 0 0
Totale 27.331